Integrative analyses identify Isthmin-1 as a candidate mediator linking metabolic dysfunction-associated steatotic liver disease and sepsis-related inflammation

Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly associated with adverse infection-related outcomes, yet the molecular mechanisms linking metabolic liver dysfunction to sepsis-related inflammation remain poorly understood. We aimed to identify candidate mediators connecting hepatic metabolic stress with systemic inflammatory injury and to explore their potential downstream metabolic programs. Methods We integrated population-based analysis of the National Health and Nutrition Examination Survey, bidirectional Mendelian randomization, cross-disease transcriptomic and weighted gene co-expression network analyses, independent liver-dataset validation, Human Protein Atlas annotation, single-nucleus/single-cell transcriptomics, a high-fat diet (HFD)/lipopolysaccharide (LPS) mouse model, and complementary in silico gene-perturbation analyses. ISM1 was further examined using scTenifoldKnk and GenKI in NAFLD hepatocytes to identify molecular programs potentially responsive to predicted ISM1 loss. Results NAFLD was associated with increased systemic inflammatory burden, while Mendelian randomization supported a modest directional association between genetic liability to NAFLD and sepsis risk. Cross-disease transcriptomic integration and independent liver validation prioritized Isthmin-1 (ISM1), which showed increased expression in NAFLD liver but decreased expression in septic liver. Single-nucleus RNA sequencing localized ISM1 predominantly to hepatocytes and revealed stage-dependent expression across the MASLD spectrum. In mice, HFD aggravated LPS-associated systemic inflammation and multiorgan injury, whereas combined HFD and LPS exposure markedly reduced hepatic ISM1 expression. Complementary in silico ISM1-knockout analyses recurrently implicated lipid-, peroxisomal-, and fatty-acid-related metabolic programs. Within the predefined fatty-acid metabolism gene set, ACSL1 emerged as a highly ranked predicted responder, while disease-cohort co-expression analyses suggested a context-dependent relationship between ISM1 and ACSL1. Conclusions Our findings prioritize ISM1 as a stress-responsive secreted protein at the metabolic–inflammatory interface of MASLD and sepsis-related injury and suggest that fatty-acid metabolism may represent a component of the predicted ISM1-responsive network. ACSL1 emerges as a candidate metabolic node rather than an established downstream target. Direct functional studies are required to determine whether ISM1 causally regulates fatty-acid metabolism and inflammatory injury.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-19
DOI
https://doi.org/10.3389/fimmu.2026.1987180
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Integrative analyses identify Isthmin-1 as a candidate mediator linking metabolic dysfunction-associated steatotic liver disease and sepsis-related inflammation

Qun Zhang, 李俊刚, Jiefei Chen, Qichen Long et al.
Frontiers in Immunology
Liver Disease Diagnosis and Treatment
article

Integrative analyses identify Isthmin-1 as a candidate mediator linking metabolic dysfunction-associated steatotic liver disease and sepsis-related inflammation

Qun Zhang, 李俊刚, Jiefei Chen, Qichen Long, Min Hu, Ziyang Li, Weilin Zhang, Fengfan Li, Weichu Zeng, Shuo Su
article en

Abstract

Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly associated with adverse infection-related outcomes, yet the molecular mechanisms linking metabolic liver dysfunction to sepsis-related inflammation remain poorly understood. We aimed to identify candidate mediators connecting hepatic metabolic stress with systemic inflammatory injury and to explore their potential downstream metabolic programs. Methods We integrated population-based analysis of the National Health and Nutrition Examination Survey, bidirectional Mendelian randomization, cross-disease transcriptomic and weighted gene co-expression network analyses, independent liver-dataset validation, Human Protein Atlas annotation, single-nucleus/single-cell transcriptomics, a high-fat diet (HFD)/lipopolysaccharide (LPS) mouse model, and complementary in silico gene-perturbation analyses. ISM1 was further examined using scTenifoldKnk and GenKI in NAFLD hepatocytes to identify molecular programs potentially responsive to predicted ISM1 loss. Results NAFLD was associated with increased systemic inflammatory burden, while Mendelian randomization supported a modest directional association between genetic liability to NAFLD and sepsis risk. Cross-disease transcriptomic integration and independent liver validation prioritized Isthmin-1 (ISM1), which showed increased expression in NAFLD liver but decreased expression in septic liver. Single-nucleus RNA sequencing localized ISM1 predominantly to hepatocytes and revealed stage-dependent expression across the MASLD spectrum. In mice, HFD aggravated LPS-associated systemic inflammation and multiorgan injury, whereas combined HFD and LPS exposure markedly reduced hepatic ISM1 expression. Complementary in silico ISM1-knockout analyses recurrently implicated lipid-, peroxisomal-, and fatty-acid-related metabolic programs. Within the predefined fatty-acid metabolism gene set, ACSL1 emerged as a highly ranked predicted responder, while disease-cohort co-expression analyses suggested a context-dependent relationship between ISM1 and ACSL1. Conclusions Our findings prioritize ISM1 as a stress-responsive secreted protein at the metabolic–inflammatory interface of MASLD and sepsis-related injury and suggest that fatty-acid metabolism may represent a component of the predicted ISM1-responsive network. ACSL1 emerges as a candidate metabolic node rather than an established downstream target. Direct functional studies are required to determine whether ISM1 causally regulates fatty-acid metabolism and inflammatory injury.

Frontiers in ImmunologyVol. 17
Second Xiangya Hospital of Central South University (CN)
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon